NCT00870038

To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study

Early Re-Endothelialization Might Not be the Unique Solution to Prevent Restenosis. The EREMUS Study

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Ospedale della Misericordia · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The investigators sought to discover which one of the following strategies is the safest for patients undergoing percutaneous coronary intervention: paclitaxel-coated balloon+Genous stent; Genous stent; drug eluting stent (paclitaxel).

Conditions

• Angioplasty, Transluminal, Percutaneous Coronary
• Percutaneous Coronary Intervention

Interventions

Type	Name	Description
DEVICE	Percutaneous coronary intervention: Paclitaxel eluting balloon (Elutax) + Genous stent	Predilatation with paclitaxel-eluting balloon, then stenting of the lesion with Genous stent
DEVICE	Percutaneous coronary intervention: Uncoated balloon + Genous stent	Predilatation with uncoated balloon, the stenting with Genous stent.
DEVICE	Percutaneous coronary intervention: Drug eluting stent (Taxus stent)	Predilatation with uncoated balloon, the placement of a Taxus stent.

Timeline

• Start date: 2010-12-01
• Primary completion: 2011-08-01
• Completion: 2012-01-01
• First posted: 2009-03-26
• Last updated: 2010-07-22

Locations

1 site across 1 country: Italy